2Thonton DJ, Khan N, Mehrotra R, et al. Saivary nucin MG1 is comprised almost entirely of different gycosylated form of the MUC5B gene oroduct. Glycobiology, 1999,9 (3) :293-302.
3Rayment SA, Liu B, Offner GD, et al. Immunoquatification of human salivary mucins MGland MG2 in stimulated whol saliva: factors influencing mucin levels. J Dent Res, 2000,79 ( 10 ) : 1765-1772.
4Mehrotra R, Thornton D J, Sheehan JK. Isolation and physical characterization of the NUC7(MG2) mucins from saliva: evidence for self-association. Biochem J, 1998,334(Pt2) :415-422.
5Tabak LA. In Defenso of the oral cavity structure biosythesis andfunction of salivary mucins. Anne Rev Physiol, 1995,57:547-564.
6Zaewska A, Zwierz K, Z61kowski K, et al. Structue and biosynthesis of human salivary mucins. Acta Biochim Pol, 2000, (4) :1067-1079.
7Slomiany BL, Murty VL, Piotrowski J, et al. Salivary mucins in oral mucosal defense. Gen Pharmacol, 1996,27 (5) :761-771.
8Gibbins HL, Yakubov GE, Proctor GB, et al. What interactions drive the salivary mucosal pellicle formation? Colloids Surf B Biointerfacs, 2014, 120: 184-192.
9Teubl B J, Absenger M, Fr~hlich E, et al. The oral cavity as biological barrier system: design of an advanced buccal in vitro permeability model. Eur J Pharm Biopharm,2013,84(2) :386-393.
10Nieuw Amerongen A~, Bolscher JG, Bloemena E, et al. Sulfomucina in the human body. Biol chem, 1998, 397( 1 ) :1-18.
